Last update 08 May 2025

ALVAC(2) Melanoma multi-antigen therapeutic vaccine(Sanofi Pasteur)

Overview

Basic Info

Drug Type
Shared antigen vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
T lymphocytes stimulants
Therapeutic Areas
NeoplasmsSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Metastatic melanoma
Originator Organization
Sanofi Pasteur SASanofi Pasteur SA
Active Organization-
Inactive Organization
Sanofi Pasteur SASanofi Pasteur SA
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ALVAC(2) Melanoma multi-antigen therapeutic vaccine(Sanofi Pasteur)
NCT00613509
/ TerminatedPhase 2
Phase II Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic Melanoma
100 Clinical Results associated with ALVAC(2) Melanoma multi-antigen therapeutic vaccine(Sanofi Pasteur)
Login to view more data
100 Translational Medicine associated with ALVAC(2) Melanoma multi-antigen therapeutic vaccine(Sanofi Pasteur)
Login to view more data
100 Patents (Medical) associated with ALVAC(2) Melanoma multi-antigen therapeutic vaccine(Sanofi Pasteur)
Login to view more data
100 Deals associated with ALVAC(2) Melanoma multi-antigen therapeutic vaccine(Sanofi Pasteur)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic melanomaPhase 2
United States
Sanofi Pasteur SASanofi Pasteur SA
01 Jun 2008
Metastatic melanomaPhase 2
Canada
Sanofi Pasteur SASanofi Pasteur SA
01 Jun 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT00613509 (CTgov)
Phase 2
Metastatic melanoma
23
(Study Group 1: ALVAC Melanoma Vaccine)
vfcyzulgus(jwkttqqnts) = arggtaiobu nhugrfdvtl (svhcepjvue, bbdkazkhsc - yssavsmhux)
View more
-
17 Dec 2010
(Study Group 2: Interferon Alpha-2b)
vfcyzulgus(jwkttqqnts) = ibizpbcvof nhugrfdvtl (svhcepjvue, sfjgpxdwpn - arwdhvwmxr)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free